Imcyse développe des immunothérapies actives et spécifiques visant à traiter et guérir des maladies chroniques sévères causées par des distorsions du système immunitaire.
Location: Belgium, Liège
Employees: 11-50
Total raised: $39.33M
Founded date: 2010
Investors 4
| Date | Name | Website |
| - | Le Groupe ... | sriw.be |
| - | SFPIM | sfpim.be |
| - | KU Leuven ... | lrd.kuleuv... |
| - | Life Scien... | lspvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.06.2019 | Series B | $39.33M | - |
Mentions in press and media 9
| Date | Title | Description |
| 03.11.2021 | Imcyse Appoints Gene Mack, MBA as Chief Financial Officer | LIÉGE, Belgium, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, today ann... |
| 03.11.2021 | Imcyse Appoints Gene Mack, MBA as Chief Financial Officer | LIÉGE, Belgium, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new class of active and specific immunotherapies for the treatment of severe autoimmune diseases, today ann... |
| 03.11.2021 | Imcyse Appoints Gene Mack, MBA as Chief Financial Officer | DGAP-News: Imcyse SA / Key word(s): Personnel Imcyse Appoints Gene Mack, MBA as Chief Financial Officer 03.11.2021 / 13:00 The issuer is solely responsible for the content of this announcement. Imcyse Appoints Gene Mack, MBA as Chief Financ... |
| 24.06.2021 | PRESS RELEASE: Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth | DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth 2021-06-24 / 14:00 The issuer is solely responsible for the content of this announcement. =-... |
| 24.06.2021 | Imcyse : appoints new Scientific Advisory Board and opens new laboratories for next phase of growth | DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth 24.06.2021 / 14:00 The issuer is solely responsible for the content of this announcement. Im... |
| 24.06.2021 | PRESS RELEASE : Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth | DGAP-News: Imcyse SA / Key word(s): Miscellaneous Imcyse appoints new Scientific Advisory Board and opens new laboratories for next phase of growth 2021-06-24 / 14:00 The issuer is solely responsible for the content of this announcement. =-... |
| 06.12.2019 | Best of 2019: 10 Belgium tech startups that scored maximum funding this year | Entrepreneurs in Belgium eyeing to raise funds might have an easier time right now to grow their rice as the startup ecosystem in the country is heating up. Not only funding but also starting a business in Belgium does not take as much effo... |
| 19.06.2019 | Belgium-based biotech startup Imcyse secures €35M Series B funding, a hope to patients with chronic diabetes | Imcyse, a developer of active specific immunotherapies for the treatment and prevention of severe chronic diseases, recently announced that it has raised €35 million ($39.5M) in a Series B financing round and through other channels. The fin... |
| 18.06.2019 | Imcyse Raises €35M in Series B Funding Round and Grants | Imcyse, a Liège, Belgium-based developer of active specific immunotherapies for the treatment and prevention of severe chronic diseases, raised €35M ($39.5M) in Series B financing round and through other channels. The round of €28M ($31.6M)... |